Redefining monocartons as secondary package will boost Indian pharma exports: Kezzler
Jayashankar Menon | @TheDollarBiz In its latest effort to tackle growing instances of fake drug scandals in India and rising concerns in the international pharma market, the Indian government has redefined monocartons for packaging drugs as a secondary package which is expected to help trace products. While, some representatives of the pharma industry in India are against the move, citing cost escalation, Dr. Avijit Chaudhuri, Chief Business Officer, Kezzler, clears the air in an exclusive interview with The Dollar Business. Excerpts: TDB: Do you support the anti-counterfeiting measures taken by the Indian government? Avijit Chaudhuri: The alarming presence of counterfeit pharma products in certain African countries and elsewhere required the Commerce Ministry to quickly move to come up ...
